We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Smart Patch Prevents Fatal Blood Clots in Mouse Model

By Gerald M. Slutzky, PhD
Posted on 09 Dec 2016
Print article
Image: A diagram of thrombin-responsive patch that releases heparin in response to thrombin (Photo courtesy of Yuqi Zhang).
Image: A diagram of thrombin-responsive patch that releases heparin in response to thrombin (Photo courtesy of Yuqi Zhang).
Tests on a mouse model of thrombosis showed that a novel "smart patch" heparin delivery system prevented clotting efficiently in a feedback-controlled manner.

An interdisciplinary team of researchers at North Carolina State University (Raleigh, USA) and the University of North Carolina (Chapel Hill, USA) had designed a smart patch comprising microneedles made of a polymer composed of hyaluronic acid (HA) and heparin.

The polymer was designed to be responsive to thrombin, an enzyme that initiates clotting in the blood. Elevated levels of thrombin in the bloodstream dissolved the amino acid chains binding heparin to HA, releasing the heparin into the blood stream.

In a paper published in the November 25, 2016, online edition of the journal Advanced Materials, the investigators described testing the smart patch on mice. Mice were either left untreated, injected with heparin, or treated with the HA-heparin smart patch 10 minutes or six hours before being injected with a lethal dose of thrombin.

All of the mice with the HA-heparin smart patch survived both treatments. Mice injected with heparin survived the 10-minute exposure, but around 80% died after six hours. All the untreated mice were killed by both treatments.

"Our goal was to generate a patch that can monitor a patient's blood and release additional drugs when necessary; effectively, a self-regulating system," said senior author Dr. Zhen Gu, assistant professor in the joint biomedical engineering program at North Carolina State University and the University of North Carolina. "We are excited about the possibility of using a closed-loop, self-regulating smart patch to help treat a condition that affects thousands of people every year, while hopefully also driving down treatment costs. This paper represents a good first step, and we are now looking for funding to perform additional preclinical testing."

Related Links:
North Carolina State University
University of North Carolina

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.